By Josh White
Date: Friday 09 May 2025
(Sharecast News) - Ondine Biomedical announced the appointment of Alan Thomas as its interim chief financial officer on Friday, with immediate effect, following the departure of Michael Behlke, who was stepping down from his role as CFO and chief operating officer for personal reasons.
By Josh White
Date: Wednesday 09 Apr 2025
(Sharecast News) - Ondine Biomedical said in an update on Wednesday that a new health economic analysis by the York Health Economics Consortium (YHEC) supported significant cost-saving potential from its 'Steriwave' nasal decolonisation technology in reducing surgical site infections across major surgeries in the UK.
By Josh White
Date: Wednesday 26 Feb 2025
(Sharecast News) - Ondine Biomedical announced the appointment of Michael Behlke as its chief financial and chief operating officer on Wednesday, strengthening its leadership team as the company advanced its commercialisation strategy.
Currency | UK Pounds |
Share Price | 8.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 13.30 |
52 Week Low | 5.63 |
Volume | 11,596 |
Shares Issued | 443.23m |
Market Cap | £37.67m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:28 | 11,596 @ 8.52p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research